Literature DB >> 7565799

Reversal of in vitro p53 squelching by both TFIIB and TFIID.

X Liu1, A J Berk.   

Abstract

p53, the protein encoded by one of the most significant human tumor suppressor genes, is a sequence-specific transcriptional activator. When activated by a double-stranded DNA break, p53 function arrests cells in G1 and can induce apoptosis. Transcriptional activation function is critical for p53 tumor suppression, although transcriptional repressing and nontranscriptional functions of p53 may contribute. p53 activation requires that it bind to TFIID through interactions with TATA box-binding protein (TBP)-associated factors and potentially with TBP. Here, we studied the mechanism of p53 activation using in vitro transcription and a sufficiently high p53 concentration to squelch activated transcription. Squelching is thought to result when target molecules that interact with activation domains are titrated by binding to excess activator. Addition of either excess TFIIB or TFIID but not other proteins required for p53-activated transcription reversed squelching by high p53 concentrations, whereas neither stimulated transcription in reactions without excess p53. These results reveal that both TFIIB and TFIID are inhibited by high concentrations of p53 and suggest that p53 activation may work through direct or indirect interactions with both TFIIB and TFIID.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565799      PMCID: PMC230898          DOI: 10.1128/MCB.15.11.6474

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II.

Authors:  Y J Kim; S Björklund; Y Li; M H Sayre; R D Kornberg
Journal:  Cell       Date:  1994-05-20       Impact factor: 41.582

2.  Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein.

Authors:  Y Shen; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

3.  Sequence-specific transcriptional activation is essential for growth suppression by p53.

Authors:  J A Pietenpol; T Tokino; S Thiagalingam; W S el-Deiry; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

4.  p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes.

Authors:  C Caelles; A Helmberg; M Karin
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

Review 5.  Cell cycle control and cancer.

Authors:  L H Hartwell; M B Kastan
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

6.  p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60.

Authors:  C J Thut; J L Chen; R Klemm; R Tjian
Journal:  Science       Date:  1995-01-06       Impact factor: 47.728

7.  Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.

Authors:  A J Wagner; J M Kokontis; N Hay
Journal:  Genes Dev       Date:  1994-12-01       Impact factor: 11.361

8.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

Review 9.  p53 and human cancers.

Authors:  D P Lane
Journal:  Br Med Bull       Date:  1994-07       Impact factor: 4.291

10.  Transcriptional activation by p53 correlates with suppression of growth but not transformation.

Authors:  T Crook; N J Marston; E A Sara; K H Vousden
Journal:  Cell       Date:  1994-12-02       Impact factor: 41.582

View more
  24 in total

1.  Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization.

Authors:  Y Nie; H H Li; C M Bula; X Liu
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription.

Authors:  M E Martin; A J Berk
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  The two Saccharomyces cerevisiae SUA7 (TFIIB) transcripts differ at the 3'-end and respond differently to stress.

Authors:  B C Hoopes; G D Bowers; M J DiVisconte
Journal:  Nucleic Acids Res       Date:  2000-11-15       Impact factor: 16.971

Review 4.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

5.  p53 Stimulates TFIID-TFIIA-promoter complex assembly, and p53-T antigen complex inhibits TATA binding protein-TATA interaction.

Authors:  J Xing; H M Sheppard; S I Corneillie; X Liu
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

6.  Core promoter elements and TAFs contribute to the diversity of transcriptional activation in vertebrates.

Authors:  Zheng Chen; James L Manley
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  General transcriptional coactivator PC4 activates p53 function.

Authors:  Sourav Banerjee; B R Prashanth Kumar; Tapas K Kundu
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

8.  Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein.

Authors:  G Farmer; P Friedlander; J Colgan; J L Manley; C Prives
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

Review 9.  TFIIB and the regulation of transcription by RNA polymerase II.

Authors:  Wensheng Deng; Stefan G E Roberts
Journal:  Chromosoma       Date:  2007-06-26       Impact factor: 4.316

10.  Phosphorylation of p53 by TAF1 inactivates p53-dependent transcription in the DNA damage response.

Authors:  Yong Wu; Joy C Lin; Landon G Piluso; Joseph M Dhahbi; Selene Bobadilla; Stephen R Spindler; Xuan Liu
Journal:  Mol Cell       Date:  2013-11-27       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.